Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$879M |
| 2 |
Bank of America
BAC
|
+$352M |
| 3 |
Intel
INTC
|
+$243M |
| 4 |
VanEck Gold Miners ETF
GDX
|
+$232M |
| 5 |
AB InBev
BUD
|
+$188M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.82B |
| 2 |
Amazon
AMZN
|
+$884M |
| 3 |
Air Products & Chemicals
APD
|
+$219M |
| 4 |
Mondelez International
MDLZ
|
+$198M |
| 5 |
WFT
Weatherford International plc
WFT
|
+$181M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 1.22% |
| 2 | Technology | 1.15% |
| 3 | Consumer Discretionary | 1.1% |
| 4 | Financials | 1.05% |
| 5 | Communication Services | 0.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HIMX
1526
CALL
Himax Technologies
HIMX
$2.38B
| $11M | 0.01% |
1,202,600
+396,000
| +49% | +$2.68M |
|
1527
Franklin Templeton
BEN
$17.8B
| $10.9M | 0.01% |
259,808
-40,387
| -13% | -$1.68M |
|
|
GBT
1528
PUT
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $10.9M | 0.01% |
296,900
+260,600
| +718% | +$6.56M |
|
1529
CALL
XPO
XPO
$22.5B
| $10.9M | 0.01% |
660,394
-913,392
| -58% | -$14.9M |
|
|
ASB.WS
1530
DELISTED
Associated Banc-Corp Warrants
ASB.WS
| $10.9M | 0.01% |
2,043,908
| – | – |
|
|
NAV
1531
CALL
DELISTED
Navistar International
NAV
| $10.9M | 0.01% |
443,700
-654,500
| -60% | -$18M |
|
1532
PUT
Stellantis
STLA
$19.8B
| $10.9M | 0.01% |
1,002,394
-25,903
| -3% | -$279K |
|
|
WWAV
1533
DELISTED
The WhiteWave Foods Company
WWAV
| $10.9M | 0.01% |
194,032
-95,070
| -33% | -$5.25M |
|
|
CY
1534
DELISTED
Cypress Semiconductor
CY
| $10.9M | 0.01% |
790,888
+168,443
| +27% | +$2.15M |
|
1535
CALL
Tenet Healthcare
THC
$21.9B
| $10.9M | 0.01% |
614,200
+208,900
| +52% | +$3.87M |
|
1536
CALL
Ross Stores
ROST
$77.4B
| $10.9M | 0.01% |
165,100
+23,700
| +17% | +$1.58M |
|
|
JOYY
1537
JOYY Inc
JOYY
$3.78B
| $10.9M | 0.01% |
235,585
-117,818
| -33% | -$5.23M |
|
1538
CALL
iShares Russell 2000 Value ETF
IWN
$14.6B
| $10.9M | 0.01% |
91,900
+33,100
| +56% | +$3.93M |
|
1539
PUT
Zimmer Biomet
ZBH
$19.1B
| $10.9M | 0.01% |
91,567
-46,453
| -34% | -$5.26M |
|
1540
PUT
Direxion Daily MSCI Emerging Markets Bull 3X ETF
EDC
$171M
| $10.8M | 0.01% |
146,700
+46,300
| +46% | +$3.1M |
|
1541
CALL
Factset
FDS
$10.5B
| $10.8M | 0.01% |
65,500
+22,400
| +52% | +$3.92M |
|
1542
Invesco CurrencyShares Euro Currency Trust
FXE
$361M
| $10.8M | 0.01% |
+104,354
| New | +$10.8M |
|
1543
PUT
Interactive Brokers
IBKR
$44.5B
| $10.8M | 0.01% |
1,242,400
+720,800
| +138% | +$6.71M |
|
|
IBDJ
1544
DELISTED
iShares iBonds Dec 2017 Term Corporate ETF
IBDJ
| $10.8M | 0.01% |
+433,836
| New | +$10.8M |
|
1545
PUT
Banco Macro
BMA
$4.97B
| $10.8M | 0.01% |
124,300
+95,100
| +326% | +$7.55M |
|
1546
PUT
Chemours
CC
$2.37B
| $10.8M | 0.01% |
279,600
-35,500
| -11% | -$1.07M |
|
1547
PUT
IQVIA
IQV
$42.7B
| $10.7M | 0.01% |
133,300
+122,100
| +1,090% | +$9.53M |
|
1548
PUT
Suncor Energy
SU
$76.4B
| $10.7M | 0.01% |
349,100
-72,800
| -17% | -$2.29M |
|
1549
CALL
Core Laboratories
CLB
$553M
| $10.7M | 0.01% |
92,800
-34,900
| -27% | -$4.06M |
|
1550
CALL
Centene
CNC
$32.1B
| $10.7M | 0.01% |
300,600
+114,000
| +61% | +$3.82M |
|
Similar funds
Jeff Yass's Q1 2017 Portfolio in Review
As of Q1 2017, Jeff Yass held 10,995 positions worth $198B, up 0.36% from $197B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Jeff Yass withdrew a net $13.1B in Q1 2017, closing 2,170 positions and reducing 3,725 holdings. Its most notable exit was Air Products & Chemicals, an estimated $219M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 1.2% of assets, down from 1.2% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Jeff Yass opened a new position in iShares MSCI EAFE ETF worth $131M.
- Jeff Yass's largest Q1 2017 buy was iShares MSCI EAFE ETF: 2,100,985 shares worth $131M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2017, an estimated $879M increase.
- Jeff Yass's biggest Q1 2017 reduction was Apple, cutting an estimated $1.82B.
- Jeff Yass fully exited Air Products & Chemicals in Q1 2017, selling an estimated $219M.
- Jeff Yass's ten largest holdings make up 22% of its $198B portfolio in Q1 2017.
- Jeff Yass opened 1,488 new positions and closed 2,170 in Q1 2017.
- Jeff Yass's portfolio value rose 0.36% quarter-over-quarter to $198B.
Based on Susquehanna International Group's 13F filing for Q1 2017, filed 15 May 2017.